Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-11

Clinical Trial Update: Ferumoxytol-enhanced Magnetic Resonance Venography in Patients With Venous Diseases [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating ferumoxytol-enhanced MR venography in patients with venous diseases, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: Min Zhou | Conditions: Venous Diseases | Phase 2 | Status: RECRUITING